Preliminary results of G>GVIELC:: A phase III trial of gemcitabine associated to vindesine or gemcitabine alone in elderly or poor performance patients with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Santo, A.
Genestreti, G.
Azzoni, P.
Palmeri, S.
Caffo, O.
Cipriani, A.
Binato, E.
Cartei, G.
Portalone, L.
Sava, T.
Molino, A. M.
Cetto, G. L.
机构：
[1] Univ Verona, Verona Hosp, Dept Oncol, I-37100 Verona, Italy
[2] GIVOP, Verona, Italy
[3] Palermo Hosp, Oncol Unit, Palermo, Italy
[4] Trento Hosp, Oncol Unit, Trento, Italy
[5] Verona Hosp, Pneumol Unit, Verona, Italy
[6] Padova Hosp, Dept Oncol, Padua, Italy
[7] Forlanini Rome Hosp, Oncopneumol Unit, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI20 / XI20
页数：1
相关论文
共 50 条
  • [21] Sequential gemcitabine and vinorelbine in elderly patients with advanced non-small cell lung cancer.: Preliminary results of a Galician multicenter phase II trial.
    Baron, FJ
    Vázquez, S
    Firvida, JL
    Grande, C
    Amenedo, M
    Ruiz, A
    Mel, JR
    Rodríguez, R
    Cueva, J
    Casal, J
    ANNALS OF ONCOLOGY, 2000, 11 : 114 - 114
  • [22] Phase III trial of the protein kinase C α (PKCα) antisense oligonucleotide Aprinocarsen plus gemcitabine/cisplatin versus gemcitabine/cisplatin alone in advanced stage non-small cell lung cancer (NSCLC):: Updated results of a randomized phase III trial
    Gandara, D
    Douillard, J
    Koralewski, P
    Manegold, C
    Smit, E
    Reyes, J
    Chang, G
    Obasaju, C
    Peterson, P
    Paz-Ares, L
    LUNG CANCER, 2005, 49 : S31 - S31
  • [23] Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Lazaro, M
    Jorge, M
    Castellanos, J
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [24] Gemcitabine (G) plus cisplatin (C) in advanced non-small cell lung cancer (NSCLC): Final phase II results.
    Casal, J
    Huidobro, G
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S68 - S68
  • [25] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Yun Fan
    Neng-ming Lin
    Sheng-lin Ma
    Lü-hong Luo
    Luo Fang
    Zhi-yu Huang
    Hai-feng Yu
    Feng-qin Wu
    Acta Pharmacologica Sinica, 2010, 31 : 746 - 752
  • [26] Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer
    Comella, P
    SEMINARS IN ONCOLOGY, 2001, 28 (02) : 7 - 10
  • [27] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Fan, Yun
    Lin, Neng-ming
    Ma, Sheng-lin
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) : 746 - 752
  • [28] A phase II of gemcitabine in advanced non-small cell lung cancer
    Koynov, K
    Tzekova, V
    Mincheva, N
    Scherer, A
    Krejcy, K
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 231 - 234
  • [29] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, A. J.
    Kalemkerian, G. P.
    Gadgeel, S. M.
    Schneider, B. J.
    Valdivieso, M.
    Venkatramanamoorthy, R.
    Hackstock, D. M.
    Chen, W.
    Heilbrun, L. K.
    Ruckdeschel, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] A PHASE II TRIAL OF PEMETREXED (P), GEMCITABINE (G), AND BEVACIZUMAB (BV) IN UNTREATED PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Wozniak, Antoinette
    Kalemkerian, Gregory
    Gadgeel, Shirish M.
    Ramnath, Nithya
    Schneider, Bryan
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah
    Chen, Wei
    Ruckdeschel, John
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1234 - S1235
12345